Cargando…
The Pharmacology of Acute Lung Injury in Sepsis
Acute lung injury (ALI) secondary to sepsis is one of the leading causes of death in sepsis. As such, many pharmacologic and nonpharmacologic strategies have been employed to attenuate its course. Very few of these strategies have proven beneficial. In this paper, we discuss the epidemiology and pat...
Autor principal: | Varisco, Brian Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130333/ https://www.ncbi.nlm.nih.gov/pubmed/21738527 http://dx.doi.org/10.1155/2011/254619 |
Ejemplares similares
-
Gut-lymph-lung pathway mediates sepsis-induced acute lung injury
por: Jin, Can, et al.
Publicado: (2020) -
Role of Extracellular microRNAs in Sepsis-Induced Acute Lung Injury
por: Xiong, Chenlu, et al.
Publicado: (2023) -
Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach
por: Yang, Ruhao, et al.
Publicado: (2021) -
Lymphatic Flow: A Potential Target in Sepsis-Associated Acute Lung Injury
por: Wu, Chenghua, et al.
Publicado: (2020) -
Mortality in sepsis versus non-sepsis induced acute lung injury
por: Sevransky, Jonathan E, et al.
Publicado: (2009)